Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Death, re-infarction, or urgent target vessel revascularization (TVR) at 30 days using adjunctive abciximab for percutaneous coronary intervention in acute myocardial infarction (MI) trials. Open bars = placebo; closed bars = abciximab. ADMIRAL = Abciximab before Direct angioplasty and stenting in Myocardial Infraction Regarding Acute and Long-term follow-up trial; CADILLAC = Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications trial; ISAR = Intracoronary Stenting and Antithrombotic Regimen trial; PTCA = percutaneous transluminal coronary angioplasty; RAPPORT = ReoPro And Primary PTCA Organization and Randomized Trial.
|
